Source: Investing.com

Pieris: Pieris Pharmaceuticals Inc receives Investment Bank Analyst Rating Update By Investing.com

Pieris Pharmaceuticals Inc receives Investment Bank Analyst Rating Update

Read full article »
Pieris's Competitors | Pieris's News | Pieris's Financials
Stay up-to-date with the latest news on Pieris
Annual Revenue
$25-100M
Employees
1-25
Stephen S. Yoder's photo - President & CEO of Pieris

President & CEO

Stephen S. Yoder

CEO Approval Rating

90/100

Read more
Stay up-to-date with the latest news on Pieris